Drugs / Y242
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01515319 | Apr 2012 → Feb 2013 | obesity disorder | Imperial College London | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Y242 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01515319 ↗ |
| Route | Subcutaneous | “Single ascending dose: subcutaneous injection of 2, 7.5, 15, 30, 60 and 90 mg Y242 (Part A)” NCT01515319 ↗ |